Novartis AG (NVS) Stock Price Today
Aura AI Summary
Key Stats
- $287.66BMarket Cap
- -Volume
- HealthSector
- $168.6252W High
- $113.5052W Low
- -Typical Hold Time
- $327.68BEnterprise Value
- 3.14%Div Yield
- -Trading Activity
Track Novartis AG (NVS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Novartis AG has traded between a low of $113.5 and a high of $168.62, highlighting its annual price range. Buy and sell Novartis AG shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Most Recent News
FDA approves Fabhalta as first drug to significantly slow kidney decline in IgAN patients
The FDA has granted traditional approval to Fabhalta (iptacopan), a first-in-class complement inhibitor, for slowing kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN). Fabhalta showed a 48% slower decline in kidney fu...
Industrial sector sentiment hits 5-year high on strong demand and capex optimism
Corbin Advisors' Q2 2026 survey shows industrial investor sentiment at its highest in five years, with 84% of participants bullish or neutral-to-bullish due to strong order momentum and demand from data centers and AI sectors. Expectations for Q2 rev...
Law firm probes Viking Therapeutics officers for possible self-dealing harming shareholders
Kuehn Law, PLLC is investigating whether certain officers and directors of Viking Therapeutics, Inc. breached their fiduciary duties through potential self-dealing. This legal inquiry could lead to shareholder damages and corporate governance reforms...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.